Cargando…
Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December 2019, and has been declared as a public health emergency by the World Health Organization. Due to the hypercoagulable state, blood stasis and endothelial injury, severe patients with COVID-19 are at high risk for th...
Autores principales: | Zhou, Bo, She, Jianqing, Wang, Yadan, Ma, Xiancang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165253/ https://www.ncbi.nlm.nih.gov/pubmed/32306290 http://dx.doi.org/10.1007/s11239-020-02084-w |
Ejemplares similares
-
The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease
por: Zhou, Bo, et al.
Publicado: (2020) -
A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis
por: Zhou, Bo, et al.
Publicado: (2020) -
Comparison of efficacy between trimetazidine and cilostazol in the treatment of arteriosclerosis obliterans in lower extremity
por: Hu, Min, et al.
Publicado: (2019) -
Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans
por: Yong, Jun, et al.
Publicado: (2019) -
Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Xiao, Deshuang, et al.
Publicado: (2022)